ENZC (Enzolytics) Market Cap: $4.83 Mil (As of Jun. 27, 2026)


What is Enzolytics Market Cap?

Enzolytics ENZC Market Cap is $4.83 Mil as of Jun. 27, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enzolytics's share price for the quarter that ended in Jun. 2011 was $55. Enzolytics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2011 was 0.06 Mil. Therefore, Enzolytics's market cap for the quarter that ended in Jun. 2011 was $3.25 Mil.

Enzolytics's quarterly market cap declined from Dec. 2010 ($7.91 Mil) to Mar. 2011 ($4.05 Mil) and declined from Mar. 2011 ($4.05 Mil) to Jun. 2011 ($3.25 Mil).

Enzolytics's annual market cap increased from Jul. 2008 ($0.00 Mil) to Dec. 2009 ($360.00 Mil) but then declined from Dec. 2009 ($360.00 Mil) to Dec. 2010 ($7.91 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enzolytics's Enterprise Value for Today is $4.83 Mil.

Enzolytics  (OTCPK:ENZC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Enzolytics Market Cap Related Terms

Enzolytics Market Cap Historical Data

* Premium members only.

The historical data trend for Enzolytics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Market Cap Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Market Cap
0.00 0.00 360.00 7.91

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 3.25 7.91 4.05 3.25

Enzolytics Market Cap Competitor Comparison

For the Biotechnology subindustry, Enzolytics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Market Cap distribution charts can be found below:

* The bar in red indicates where Enzolytics's Market Cap falls into.


Enzolytics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Enzolytics's Market Cap for the fiscal year that ended in Dec. 2010 is calculated as

Market Cap (A: Dec. 2010 )=Share Price (A: Dec. 2010 )*Shares Outstanding (EOP) (A: Dec. 2010 )
=$155*0.051
=$7.91

Enzolytics's Market Cap for the quarter that ended in Jun. 2011 is calculated as

Market Cap (Q: Jun. 2011 )=Share Price (Q: Jun. 2011 )*Shares Outstanding (EOP) (Q: Jun. 2011 )
=$55*0.059
=$3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $4.83 Mil mean?
Enzolytics (ENZC) has a Market Cap of $4.83 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enzolytics and its competitors.
Is Enzolytics' Market Cap too high?
Enzolytics' current Market Cap is $4.83 Mil. The Biotechnology industry median Market Cap is 113.83. Enzolytics' value of $4.83 Mil is 95.8% below this industry median.
How does Enzolytics' Market Cap compare to competitors?
Enzolytics' Market Cap of $4.83 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 113.83. Enzolytics' value of $4.83 Mil is 95.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Enzolytics's current Market Cap of $4.83 Mil is 95.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enzolytics and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enzolytics's current Market Cap is $4.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Market Cap of $4.83 Mil. The current Market Cap is $4.83 Mil and 95.8% below the Biotechnology industry median of 113.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Enzolytics (ENZC), the current Market Cap is $4.83 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.